J&J Trying To Back Out Of 77 Risperdal Deals, Plaintiffs Say
A group of nearly 80 plaintiffs pursuing lawsuits against a Johnson & Johnson subsidiary in Pennsylvania state court over injuries they allegedly suffered from the antipsychotic drug Risperdal said last week...To view the full article, register now.
Already a subscriber? Click here to view full article